5-[BIS(TERT-BUTYL)PHOSPHINO]-1-(1-NAPHTHALENYL)-1H-PYRAZOLE
- $185 - $671.86
- Product name: 5-[BIS(TERT-BUTYL)PHOSPHINO]-1-(1-NAPHTHALENYL)-1H-PYRAZOLE
- CAS: 894085-97-3
- MF: C21H27N2P
- MW: 338.43
- EINECS:
- MDL Number:MFCD09038825
- Synonyms:NAPPYPHOS;5-[BIS(TERT-BUTYL)PHOSPHINO]-1-(1-NAPHTHALENYL)-1H-PYRAZOLE;5-(DI-TERT-BUTYLPHOSPHINO)-1-(NAPHTHALEN-1-YL)-1H-PYRAZOL;5-(Di-tert-butylphosphino)-1-(naphthalen-1-yl)-1H-pyrazole;5-[Bis(1,1-dimethylethyl)phosphino]-1-(1-naphthalenyl)-1H-pyrazole;5-(Di-t-butylphosphino)-1-(naphthalen-1-yl)-1H-pyrazole, 97%;1H-Pyrazole, 5-[bis(1,1-dimethylethyl)phosphino]-1-(1-naphthalenyl)-;ditert-butyl-(2-naphthalen-1-ylpyrazol-3-yl)phosphane
2 prices
Selected condition:
Brand
- American Custom Chemicals Corporation
- Sigma-Aldrich
Package
- 100MG
- ManufacturerAmerican Custom Chemicals Corporation
- Product numberCHM0115347
- Product description5-(DI-TERT-BUTYLPHOSPHINO)-1-(NAPHTHALEN-1-YL)-1H-PYRAZOLE 95.00%
- Packaging100MG
- Price$671.86
- Updated2021-12-16
- Buy
- ManufacturerSigma-Aldrich
- Product number710598
- Product description5-(Di-tert-butylphosphino)-1-(naphthalen-1-yl)-1H-pyrazole 97%
- Packaging100mg
- Price$185
- Updated2024-03-01
- Buy
Manufacturer | Product number | Product description | Packaging | Price | Updated | Buy |
---|---|---|---|---|---|---|
American Custom Chemicals Corporation | CHM0115347 | 5-(DI-TERT-BUTYLPHOSPHINO)-1-(NAPHTHALEN-1-YL)-1H-PYRAZOLE 95.00% | 100MG | $671.86 | 2021-12-16 | Buy |
Sigma-Aldrich | 710598 | 5-(Di-tert-butylphosphino)-1-(naphthalen-1-yl)-1H-pyrazole 97% | 100mg | $185 | 2024-03-01 | Buy |
Properties
Melting point :127-131°C
Boiling point :466.8±18.0 °C(Predicted)
pka :1.24±0.19(Predicted)
Boiling point :466.8±18.0 °C(Predicted)
pka :1.24±0.19(Predicted)
Safety Information
Symbol(GHS): | |||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Signal word: | Warning | ||||||||||||||||||||||||||||
Hazard statements: |
|
||||||||||||||||||||||||||||
Precautionary statements: |
|